MAPT and Alzheimer disease: Furthermore, RNA binding drives the conformational change of tau and the oligomerization of TDP-43, associated with Alzheimer’s disease and FTD/ALS, respectively (McMillan et al., 2023; Pérez-Berlanga et al., 2023).